Amyloidosis in familial Mediterranean fever patients: Correlation with MEFV genotype and SAA1 and MICA polymorphisms effects

BMC Medical Genetics

Volumn 5, Issue , 2004, Pages

  Medlej Hashim, Myrna ^a   Delague, Valérie ^a   Chouery, Eliane ^a   Salem, Nabiha ^a   Rawashdeh, Mohammed ^b   Lefranc, Gérard ^c   Loiselet, Jacques ^a   Mégarbane, André ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c CNRS and University Montpellier II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN MEFV; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; AMYLOIDOSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FAMILIAL MEDITERRANEAN FEVER; FEVER; FREQUENCY ANALYSIS; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; KIDNEY AMYLOIDOSIS; MAJOR CLINICAL STUDY; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RECESSIVE INHERITANCE; SEQUENCE ANALYSIS; THORAX PAIN;

ADOLESCENT; ADULT; ALLELES; AMYLOIDOSIS; CHILD; CHILD, PRESCHOOL; CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GENE FREQUENCY; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PROTEINS; SERUM AMYLOID A PROTEIN;

EID: 2542487537     PISSN: 14712350     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2350-5-4     Document Type: Article

References (26)

1. Sohar E, Gafni J, Pras M, Heller H: Familial Mediterranean fever. A survey of 470 cases and review of the literature. Ann J Med 1967, 43:227-253.
2. Konstantopoulos K, Michael S, Kanta A, Pecheux C, Grateau J, Helioti H, Stathakis C: Renal amyloidosis as a first manifestation of Familial Mediterranean Fever. Scand J Rheumatol 2000, 29:129-130.
3. The repertory of Familial Mediterranean Fever (FMF) and Hereditary Autoinflammatory Disorders Mutations [http:// fmf.igh.cnrs.fr/infevers/]
4. French FMF Consortium: A candidate gene for familial Mediterranean fever. Nat Genet 1997, 17:25-31.
5. International FMF Consortium: Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997, 90:797-807.
6. Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, Dross C, Dupont M, Notarnicola C, Levy M, Rosner I, Demaille J, Touitou I: Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998, 6:95-97.
7. Cazeneuve C, Sarkisian T, Pêcheux C, Dervichian M, Nédelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dodé C, Grateau G, Amselem S: MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-Genetic and therapeutic implications. Am J Hum Genet 1999, 65:88-97.
8. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Lotan R, Ogur G, Sirin A, Schlezinger M, Halpern GJ, Schwabe A, Kastner D, Rotter JI, Fischel-Ghodsian N: Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999, 7:287-292.
9. Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M, Halpern GJ, Rotter JI, Fischel-Ghodsian N, Danon YL, Shohat M: Familial Mediterranean fever: Effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000, 105(5):E70.
10. Ben-Chetrit E, Backenroth R: Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis 2001, 60(2):146-149.
11. Mansour I, Delague V, Cazeneuve C, Dodé C, Chouery E, Pĉheux C, Medlej-Hashim M, Salem N, El Zein L, Levan-Petit I, Lefranc G, Goossens M, Delpech M, Amselem S, Loiselet J, Grateau G, Mégarbané A, Naman R: Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek orthodoxes, Greek catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations. Eur J Hum Genet 2001, 9:51-55.
12. Tekin M, Yalçinkaya F, Cakar N, Akar N, Misirlioglu M, Tastan H, Tümer N: MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet 2000, 57:430-434.
13. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Geneviève D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S: Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000, 67:1136-1143.
14. Gershoni-Baruch R, Brik R, Zachs N, Shinawi M, Lidar M, Livneh A: The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003, 48(4):1149-1155.
15. Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, Koné-Paut I: The MICA region determines the first modifier locus in familial Mediterranean fever. Arth Rheum 2001, 44(1 ):163-169.
16. Miller SA, Dynes DD, Polesky F: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
17. Medlej-Hashim M, Rawashdeh M, Chouery E, Mansour I, Delague V, Lefranc G, Naman R, Loiselet J, Mégarbané A: Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients. Hum Mutat 2000, 15(4):384.
18. Morigushi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nashinarita M, Uchida S, Nakajima A, Kim SY, Chen CL, Kamatani N: Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999, 105:360-366.
19. Friedman S, Janowitz F: Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin North America 1998, 27(3):595-614.
20. Baba S, Takahashi T, Kasama T, Shirasawa H: Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis. Biochim Biophys Acta 1992, 1180:195-200.
21. Sipe JD, Colten HR, Goldberger G, Edge MD, Tack BF, Cohen AS, Whitehead AS: Human serum amyloid A (SAA): Biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry 1985, 24:2931-2936.
22. Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB: SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998, 5(4):262-265.
23. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, Yamazaki M, Watanabe K, Goto K, Nakamura S, Bahram S, Inoko H: Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci USA 1997, 94:1298-1303.
24. Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Rio J, Rodriguez Pérez A, Chaim Brautbar , Lopez-Larrea C: The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arth Rheum 1999, 42(5):1010-1016.
25. Kawabata Y, Ikegami H, Kawagushi Y, Fujisawa T, Hotta M, Ueda H, Shintani M, Nojima K, Ono M, Nishino M, Taniguchi H, Noso S, Yamada K, Babaya N, Ogihara T: Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum Immunol 2000, 61:624-629.
26. Lee YJ, Huang FY, Wang CH, Lo FS, Tsan KW, Hsu CH, Huang CY, Chang SC, Chang JG: Polymorphism in the transmembrane region of the MICA gene and type 1 diabetes. J Pediatr Endocrinol Metab 2000, 13:489-496.